[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352759-105":59,"doc-detail-352759-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","microbiota-as-a-modulator-of-drug-response-targeting-microbialdrug-crosstalk-in-cancer-therapy","Microbiota as a modulator of drug response - targeting microbial–drug crosstalk in cancer therapy","","Mechanistic links between the microbiota and anticancer treatment efficacy connect gut, intratumoral, and other tissue-associated microbial communities with differential responses across malignancies. Distinct microbial compositional and functional profiles correlate with variable outcomes to chemotherapy, immunotherapy, and targeted agents. Microbes can reduce drug activity through metabolic inactivation or structural changes, or enhance responses by increasing tumor susceptibility, while also shaping the tumor immune microenvironment via antigen presentation, effector function, or immunosuppressive myeloid polarization. Key needs include proving causation and developing biomarkers and microbiota-directed, safe strategies that enable patient stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiota-as-a-modulator-of-drug-response-targeting-microbialdrug-crosstalk-in-cancer-therapy/352759/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiota-as-a-modulator-of-drug-response-targeting-microbialdrug-crosstalk-in-cancer-therapy/352759.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-13","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does microbiota influence anticancer drug response?","Question",{"text":112,"@type":113},"Microbial communities modulate drug activity through metabolic inactivation or structural modification of anticancer compounds, or by enhancing tumor-cell susceptibility.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What roles do gut and intratumoral microbiota play in cancer therapy?",{"text":117,"@type":113},"Distinct compositional and functional profiles of microbial ecosystems correlate with differential responses to chemotherapy, immunotherapy, and targeted agents in both clinical and experimental systems.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune mechanisms are affected by microbial–drug crosstalk?",{"text":121,"@type":113},"Microbes can foster antitumor immunity by augmenting antigen presentation and effector-cell function, or constrain immune responses through regulatory networks and immunosuppressive myeloid polarization.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352759,1790135350,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","GUT MICROBES  \n2026, VOL. 18, NO. 1, 2651930  \n[https://doi.org/10.1080/19490976.2026.2651930](https://doi.org/10.1080/19490976.2026.2651930)  \nREVIEW ARTICLE     \nMicrobiota as a modulator of drug response: targeting microbial–drug crosstalk in cancer therapy  \nTianhao Zhaoa, b, Mingren Liua, b, Lei Qiua, b, Hao Zhangc, Nan Zhangd, Zaoqu Liue, Zhiwei Xiaf, Peng Luog, Jun Huanga, b and Quan Chenga, b, h, i,j  \naDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, People's Republic of China; bNational Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Central South University, Changsha, People's Republic of China; cDepartment of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China; dCollege of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, People's Republic of China; eInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; fDepartment of Neurology, Hunan Aerospace Hospital, Hunan Normal University, Changsha, People's Republic of China; gDepartment of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China; hDepartment of Neurosurgery, Xiangya School of Medicine, Central South University, Changsha, People's Republic of China; iWestern Institute of Digital-Intelligent Medicine, Chongqing, People's Republic of China; jDepartment of Neurosurgery, Xiangya Hospital, Central South University, Jiangxi, (National Regional Center for Neurological Diseases), Nanchang, People's Republic of China  \nABSTRACT  \nIn recent years, accumulating evidence has established mechanistic connections between the microbiota and the efficacy of anticancer treatments, encompassing microbial communities residing in the gut, within tumors, and across other tissue sites. Across diverse malignancies, distinct compositional and functional profiles of these microbial ecosystems have been associated with differential responses to chemotherapy, immunotherapy, and targeted agents, as observed in both clinical settings and experimental systems. It is now understood that microbial communities exert influence on drug activity through multiple pathways: they may compromise therapeutic efficacy by metabolic inactivation or structural modification of anticancer compounds, or, conversely, potentiate responses by enhancing tumor cell susceptibility. Furthermore, these communities modulate the tumor immune microenvironment, fostering antitumor immunity through augmented antigen presentation and effector cell function, or constraining immune responses via regulatory networks and immunosuppressive myeloid polarization. The crosstalk between microbial cues and signaling networks in malignant and surrounding stromal tissues is widely thought to influence therapeutic outcomes. Key challenges ahead involve proving causation, elucidating contextdependent mechanisms, and translating patient heterogeneity into robust biomarkers and targeted therapies. Anticancer interventions can reportedly alter microbial community structure and function, with therapy-associated dysbiosis potentially contributing to primary or acquired resistance. Microbiota-directed strategies, including transplantation, defined microbial consortia, targeted delivery systems, and lifestyle interventions, are under investigation, yet challenges remain in establishing causality, ensuring safety, and enabling patient stratification. Collectively, these insights establish a translational framework for rationally designed microbiota‒drug combination strategies aimed at enhancing anticancer therapeutic outcomes.  \nARTICLE HISTORY  \nReceived 21 July 2025 Accepted 24 March 2026 Revised 7 March 2026  \nKEYWORDS  \nGut microbiota; intratumoral microbiota; drug resistance; tumor immunotherapy; microbiota metabolites; microbiota-targeted therapy  \n1 Introduction ","cbCaipIUu10KAoaw","https://ap.wps.com/l/cbCaipIUu10KAoaw","pdf",7459637,34,"English","# Introduction\n## Microbiota composition and dysbiosis in cancer\n## Drug response modulation via microbial–drug crosstalk\n## Tumor immune microenvironment effects\n## Challenges and future translational directions","[{\"question\":\"How does microbiota influence anticancer drug response?\",\"answer\":\"Microbial communities modulate drug activity through metabolic inactivation or structural modification of anticancer compounds, or by enhancing tumor-cell susceptibility.\"},{\"question\":\"What roles do gut and intratumoral microbiota play in cancer therapy?\",\"answer\":\"Distinct compositional and functional profiles of microbial ecosystems correlate with differential responses to chemotherapy, immunotherapy, and targeted agents in both clinical and experimental systems.\"},{\"question\":\"What immune mechanisms are affected by microbial–drug crosstalk?\",\"answer\":\"Microbes can foster antitumor immunity by augmenting antigen presentation and effector-cell function, or constrain immune responses through regulatory networks and immunosuppressive myeloid polarization.\"}]","Microbiota as a modulator of drug response - targeting microbial–drug crosstalk in cancer therapy | PDF",1790101255,86,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb2ac792df0b22df3b31ecec78678d64.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a56daa83fe79f664d5e1c9f0c41e08dd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb9c37e2bacd7cd3950d0edb92231a2a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1005acc7d5a3b78581d7f447b88f2ac1.webp",980,1306]